Stem Cell Banking the future treatment of illnesses with stem cells
To be able to support the future treatment of illnesses with stem cells, it is advisable to store stem cells at a reliable Stem Cell Bank. Premium (Private) Stem Cell Banking and Public Stem Cell Banking under one roof are becoming the core competence of future success, linking stem cell banking Know how actively with potential therapeutic application.
Stem cell banking has been for more than 20 years available in the market. In the beginning, stem cells had been harvested from bone marrow to treat leukemia. Today we know that stem cells are available in almost all parts of our body. Stem cells can be collected from Embryonic and non-embryonic “Adult Stem Cells.” We are supporting the common adult stem cell activities of none Embryonic cells; this also avoids any unnecessary ethical discussion on R&D and treatment in this 21st-century science field.
Today stem cells can be harvested from many places of our body. Widespread is the collection of stem cells from bone marrow, placentas, umbilical cord tissue, and cord blood. More recently this had been expanded to adult stem cells from deciduous Baby teeth’s (Milk teeth’s), menstrual blood, adipose tissues (fat-Cells), peripheral blood, and even urine.
Stem cells are harvested from the blood left in a baby’s umbilical cord, the cord tissue, or placenta after its birth, via a mini-liposuction from adipose tissue (fat) or a specific bone marrow harvesting method. We are showing the cord blood harvesting process in the YouTube video from Stem-Health Hellas, a European Stem Cell Bank.
The cord blood is then analyzed, stem cells are separated, processed and cryopreserved. Cryopreservation is the freezing in nitrogen where the growth process is halted for the stem cells until again unfrozen for future medical use.
The advantage of cryopreserving stem cells is that if they harvested at an early stage of life, it is believed that stem cell in an early stage of life has better regeneration capabilities. Stem cells, harvested today (2016) from adipose tissue and bone marrow, are already used in many stem cell clinics for investigational, autologous (own) stem cell therapeutic treatments without expansion. Expansion of stem cells, before re-injected into the human body has the advantage that their therapeutic effect, may increase due to the higher quantity of stem cell population in the body.
For an informative view on stem cell potential, we are using the video from American CryoStem on YouTube, describing the future of adult stem cells from adipose tissue, fat cells, from liposuction.
In the last years (2014), it became evident, that the collection of stem cells (mesenchymal stem cells) from adipose tissues may be generating 500 times larger quantities than usually obtained from bone marrow harvesting. This advantage appears to have changed in recent times due to new harvesting methods from bone marrow.
The collection of adult stem cells, from adipose tissue or bone marrow, can be performed much later in life as often the time to collect stem cells from the umbilical cord at the birth of a child or from baby teeth had not been performed.
Therefore, while healthy, besides the storage of stem cells from baby’s, Adult Stem Cell Banking may well become the “natural safety net” we can create to treat potential illnesses at a later time in life.
This “natural safety net” philosophy is certainly a valid option already with today’s Know how and information standard as Experimental Stem cell treatment becomes more and more available in some countries as a new medical alternative where other medication does not show the required result.
At this moment (November 2014), 2214 clinical studies are underway and registered at Clinical Trials.gov (Search mode: clinical trials – stem cell trials) to support the medical claims made in helping to improve the image of being a none proven, experimental treatment only.
Furthermore, stem cell treatment will advance as a “surgical medical procedure” with fresh, non-expanded autologous stem cells from bone marrow and adipose tissues (fat tissues) in a qualified out-patient clinic as a patient-funded experimental stem cell therapy. In 2016 it is estimated that more than 400 clinics globally are using non-expanded autologous stem cells for various investigational therapeutic treatments.
Many scientists and physicians believe, that the 21st century will be the century of Biological and Medical Revolution like the last century was for electronics, computers and communication devices. This trend is already proven by the nearly daily news flow – see our info bar on the right side – of advances in tissue engineering and stem cell technology. Unfortunately, some non-qualified clinics and physicians are creating a bad image, which is true like shown in the somehow “constructed” report of “60 Minutes”……. (embedding, unfortunately, is disabled)
….. mentioning also, in that time, that mainstream medicine and some scientists are not yet believing that stem cells are a viable option for treatment of so far untreatable illnesses.
What is, however, at a certain time (The 60 minutes report is from 09. Jan. 2012!) correct, maybe tomorrow already outdated knowledge as scientific knowledge and qualified application is expanding exponentially and the more than 500 stem cell clinics in 2016, just 4 years later, demonstrate that Know how and its application is advancing rapidly.
Stem cell treatment with IRB approved protocols in qualified clinics with patient funded stem cell studies, being recorded, analyzed and published are certainly today in 2017, not falling into the “60 Minutes” treatment report category!
In our assessment, stem cell banking will become more and more the interface between technological advances and applied therapeutic treatment.
A modern stem cell bank has enlarged its activities from simple harvesting of stem cells from the umbilical cord to cryo-preserve adult stem cells and engages in investigational therapies to support the treatment potential of stem cells.
Stem cells have shown in animal models and experimental human treatments to heal and restore skin, bones, cartilage, muscles, nerves and other tissues which have become damaged through injury or diseases. By choosing to bank your, or / and your child’s stem cells now, you are building a “valuable safety net”, a “natural insurance” that will always be there to potentially safeguard your future as treatments become available for a growing number of diseases such as Cancer, Heart Diseases, Diabetes, Alzheimer’s, Multiple Sclerosis and many more.
In respect of stem cell banking, we like to draw attention to the FDA and EMA regulations. After being cryopreserved, stem cells should be thawed and expanded to be effective in any stem cell treatment. Expanding of stem cells is however neither at the FDA nor EMA allowed, as it constitutes a more than minimal manipulation and the stem cells than becomes a drug, regulated accordingly to drug regulations, like the need for clinical trials to determine safety and efficacy.
Qualified stem cell banks have also an export license for their cryopreserved stem cells, which allows them to ship the stem cells to a country where stem cell treatment with expanded stem cells is allowed. We know of two companies having even a joint venture with a foreign company in a country where this method is already authorized. If you like to know more please contact us as shown below.
ARISTOLOFT is supporting stem cell development, and you are just a click away for a first unbinding contact and more information about banking and treatment with stem cells.
As we are embedded in Western regulations, not allowing the promotion of unapproved medicine or medical treatment, we need to draw your attention to our disclaimer, that we are not promoting any unauthorized medicine nortreatments and that any information given inour website had not been reviewed nor approved by FDA / EMA and therefore reflects opinions for educational/informative purpose only.